DeNovo Ventures
96
21M
39
4.00
14
0.59
20
- Stages of investment
- Areas of investment
Summary
In 2000 was created DeNovo Ventures, which is appeared as VC. The main office of represented VC is situated in the Saratoga. The venture was found in North America in United States.
The top amount of exits for fund were in 2019. The real fund results show that this VC is 5 percentage points less often commits exit comparing to other companies. Comparing to the other companies, this DeNovo Ventures performs on 11 percentage points less the average number of lead investments. The important activity for fund was in 2007. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 2-6 deals per year. When the investment is from DeNovo Ventures the average startup value is 100-500 millions dollars.
The fund was created by David M. Mauney, Richard Ferrari. We also calculated 4 valuable employees in our database.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline EndoGastric Solutions, EBR Systems, TRIA Beauty Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical, Biopharma. The fund has specific favorite in a number of founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the DeNovo Ventures, startups are often financed by Advanced Technology Ventures, Delphi Ventures, Versant Ventures. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, SV Health Investors, Prism Venture Management. In the next rounds fund is usually obtained by SV Health Investors, Johnson & Johnson Development Corporation, Foundation Medical Partners.
Investments analytics
Analytics
- Total investments
- 96
- Lead investments
- 14
- Exits
- 20
- Rounds per year
- 4.00
- Follow on index
- 0.59
- Investments by industry
- Health Care (76)
- Medical Device (60)
- Biotechnology (47)
- Medical (34)
- Health Diagnostics (16) Show 19 more
- Investments by region
-
- United States (95)
- Peak activity year
- 2007
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Avg. valuation at time of investment
- 7M
- Group Appearance index
- 0.96
- Avg. company exit year
- 11
- Avg. multiplicator
- 0.18
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Milo | 08 Jan 2023 | Information Technology, Consumer Electronics, Communication Hardware, Audio | Early Stage Venture | 12M | |
OncoMed Pharmaceuticals | 04 Nov 2008 | Biotechnology, Health Care, Pharmaceutical | Early Stage Venture | 154M | United States, California, Redwood City |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.